Olanzapine in Anorexia Cachexia Syndrome Among Advanced Cancer Patients
Condition: Anorexia Interventions: Drug: Olanzapine 5 MG; Drug: Placebo Sponsor: Cairo University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2022 Category: Research Source Type: clinical trials
Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer
Conditions: Olanzapine; CINV; Testicular Cancer by AJCC V6 and V7 Stage; Cisplatin Interventions: Drug: Olanzapine Tablets; Drug: Placebo Sponsor: Shi Yanxia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2022 Category: Research Source Type: clinical trials
Olanzapine in Anorexia Cachexia Syndrome Among Advanced Cancer Patients
Condition: Anorexia Interventions: Drug: Olanzapine 5 MG; Drug: Placebo Sponsor: Cairo University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2022 Category: Research Source Type: clinical trials
Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer
Conditions: Olanzapine; CINV; Testicular Cancer by AJCC V6 and V7 Stage; Cisplatin Interventions: Drug: Olanzapine Tablets; Drug: Placebo Sponsor: Shi Yanxia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2022 Category: Research Source Type: clinical trials
Olanzapine in Anorexia Cachexia Syndrome Among Advanced Cancer Patients
Condition: Anorexia Interventions: Drug: Olanzapine 5 MG; Drug: Placebo Sponsor: Cairo University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2022 Category: Research Source Type: clinical trials
Fosaprepitant , Tropisetron and Olanzapine for the Prevention of Nausea and Vomiting in Patients With Breast Cancer Receiving Anthracycline/Cyclophosphamide-containing Chemotherapy
Condition: Chemotherapy-induced Nausea and Vomiting Interventions: Drug: Fosaprepitant , Tropisetron and Olanzapine; Drug: Fosaprepitant , Tropisetron, Dexamethasoneand Olanzapine Sponsor: Henan Cancer Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2022 Category: Research Source Type: clinical trials